Single-staged laryngotracheal reconstruction for idiopathic tracheal stenosis.

Background: This study retrospectively evaluated the results of surgically treated idiopathic tracheal stenosis.

Methods: Of the 220 patients surgically treated for idiopathic subglottic and tracheal stenosis in the participating hospitals, we reviewed the surgical records of all patients with idiopathic tracheal stenosis. This subgroup required resection of all of the involved mucosa but frequently had undergone more conservative treatments that damaged the tracheal mucosa and cartilage and complicated the definitive surgical treatment.

Surgical management of benign tracheal stenosis.

This chapter provides a step-by-step explanation of the indications, basic technique and pitfalls of tracheal surgery for cases of benign tracheal stenosis. Approach, trachea dissection and end-to-end anastomosis in tracheal surgery is described in detail. An algorithm for laryngotracheal technique selection according to different criteria (stenosis location, vocal cords status and tracheal mucosa and/or cartilaginous larynx involvement) is also depicted.

Glottis and subglottis: a thoracic surgeon's perspective.

Anatomically, the larynx presents several unique features that account for the difficulties in the surgical management of pathologies, such as benign strictures located in the area. These features include its unique cartilaginous support, its short length, its intrinsic and extrinsic musculatures, and its innervation, all of which are fundamental for the function of breathing, phonation, and swallowing. It is important that the thoracic surgeon operating on the larynx understand this particular anatomy, the limits of surgery, and most importantly the steps to be taken to avoid catastrophic complications.

Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.

Purpose: To assess the activity of induction chemotherapy followed by surgery in stage IIIA and selected stage IIIB non-small-cell lung cancer patients.

Patients And Methods: Mediastinoscopy proof of either positive N2 (IIIA) or T4N0-1 (IIIB) disease was required. Induction therapy was three cycles of cisplatin/gemcitabine/docetaxel, followed by surgery.